Cullinan Therapeutics, Inc. (CGEM) vs Kura Oncology, Inc. (KURA)
A side-by-side comparison of Cullinan Therapeutics, Inc. and Kura Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGEM
Cullinan Therapeutics, Inc.
$17.16HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
KURA
Kura Oncology, Inc.
$10.71HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
Total return — CGEM vs KURA
growth of $100 · dividends reinvested · last 6yCGEM -46.4% (-9.9%/yr)KURA -72.9% (-19.5%/yr)CGEM compounded faster over this window
CGEM KURA
CGEM vs KURA: by the numbers
- •CGEM is the larger company ($1.05B vs $951M market cap).
- •Both run net losses; CGEM's is the smaller (0.00% vs -384.30% net margin).
Metrics side by side
Valuation
| Metric | CGEM | KURA |
|---|---|---|
| P/S ratio | N/A | 12.31 |
| P/B ratio | 3.28 | 19.63 |
Profitability
| Metric | CGEM | KURA |
|---|---|---|
| Gross margin | 0.00% | 94.73% |
| Operating margin | 0.00% | -449.94% |
| Net margin | 0.00% | -384.30% |
| ROE | -63.62% | -612.78% |
| ROIC | -68.64% | -67.13% |
Growth (annualized)
| Metric | CGEM | KURA |
|---|---|---|
| Total return CAGR (5Y) | -7.48% | -10.73% |
Frequently asked
- How have CGEM and KURA total returns compared?
- Over the past 5 years, CGEM delivered -7.48% and KURA delivered -10.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.